Amunix Pharmaceuticals, Inc.
Records under this name other than the patents Amunix Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 33 patents it holds.
Showing 1 to 2 of 2 · Back to Amunix Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,492,530 | Unstructured Recombinant Polymers and Compositions Comprising Same Term ended Term ended Oct 23, 2026 · High confidence | Term ended | Term ended Oct 23, 2026 | High confidence |
| US 9,938,331 | Biologically Active Proteins Having Increased in Vivo And/Or in Vitro Stability Term ended Term ended Sep 27, 2026 · Medium confidence | Term ended | Term ended Sep 27, 2026 | Medium confidence |